1. "Stapling" scFv for multispecific biotherapeutics of superior properties. Issue 1 (31st December 2023) Authors: Boucher, Lauren E.; Prinslow, Elisabeth Geyer; Feldkamp, Michael; Yi, Fang; Nanjunda, Rupesh; Wu, Sheng-Jiun; Liu, Tun; Lacy, Eilyn R.; Jacobs, Steven; Kozlyuk, Natalia; Del Rosario, Brian; Wu, Bingyuan; Aquino, Patricia; Davidson, Robert C.; Heyne, Samantha; Mazzanti, Nicholas; Testa, James; Die... Journal: MAbs Issue: Volume 15:Issue 1(2023) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 'Characterization of monoclonal antibodies generated to the 287–302 amino acid loop of the human epidermal growth factor receptor'. (29th November 2019) Authors: Ho, Eric Chun Hei; Antignani, Antonella; Sarnovsky, Robert; FitzGerald, David Journal: Antibody therapeutics Issue: Volume 2:Number 4(2019) Page Start: 88 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 'In-Format' screening of a novel bispecific antibody format reveals significant potency improvements relative to unformatted molecules. Issue 1 (2nd January 2017) Authors: Scott, Martin J.; Lee, Jennifer A.; Wake, Matthew S.; Batt, Kelly V.; Wattam, Trevor A.; Hiles, Ian D.; Batuwangala, Thil D.; Ashman, Claire I.; Steward, Michael Journal: MAbs Issue: Volume 9:Issue 1(2017) Page Start: 85 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 10th European immunogenicity platform open symposium on immunogenicity of biopharmaceuticals. Issue 1 (1st January 2020) Authors: Tourdot, S.; Abdolzade-Bavil, A.; Bessa, J.; Broët, P.; Fogdell-Hahn, A.; Giorgi, M.; Jawa, V.; Kuranda, K.; Legrand, N.; Pattijn, S.; Pedras-Vasconcelos, J. A.; Rudy, A.; Salmikangas, P.; Scott, D. W.; Snoeck, V.; Smith, N.; Spindeldreher, S.; Kramer, D. Journal: MAbs Issue: Volume 12:Issue 1(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 501Y.V2 and 501Y.V3 variants of SARS-CoV-2 lose binding to bamlanivimab in vitro. Issue 1 (1st January 2021) Authors: Liu, Haolin; Wei, Pengcheng; Zhang, Qianqian; Chen, Zhongzhou; Aviszus, Katja; Downing, Walter; Peterson, Shelley; Reynoso, Lyndon; Downey, Gregory P.; Frankel, Stephen K.; Kappler, John; Marrack, Philippa; Zhang, Gongyi Journal: MAbs Issue: Volume 13:Issue 1(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. 89Zr-mAb3481 PET for HER3 tumor status assessment during lapatinib treatment. Issue 8 (17th November 2017) Authors: Pool, Martin; Kol, Arjan; de Jong, Steven; de Vries, Elisabeth G. E.; Lub-de Hooge, Marjolijn N.; Terwisscha van Scheltinga, Anton G.T. Journal: MAbs Issue: Volume 9:Issue 8(2017) Page Start: 1370 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. A bispecific antibody effectively neutralizes all four serotypes of dengue virus by simultaneous blocking virus attachment and fusion. Issue 3 (2nd April 2016) Authors: Shi, Xin; Deng, Yongqiang; Wang, Huajing; Ji, Guanghui; Tan, Wenlong; Jiang, Tao; Li, Xiaofeng; Zhao, Hui; Xia, Tian; Meng, Yanchun; Wang, Chao; Yu, Xiaojie; Yang, Yang; Li, Bohua; Qin, E-De; Dai, Jianxin; Qin, Cheng-Feng; Guo, Yajun Journal: MAbs Issue: Volume 8:Issue 3(2016) Page Start: 574 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. A bivalent, bispecific Dab-Fc antibody molecule for dual targeting of HER2 and HER3. Issue 1 (1st January 2021) Authors: Rau, Alexander; Kocher, Katharina; Rommel, Mirjam; Kühl, Lennart; Albrecht, Maximilian; Gotthard, Hannes; Aschmoneit, Nadine; Noll, Bettina; Olayioye, Monilola A.; Kontermann, Roland E.; Seifert, Oliver Journal: MAbs Issue: Volume 13:Issue 1(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. A blocking antibody against canine CSF-1R maturated by limited CDR mutagenesis. (12th August 2020) Authors: Beirão, Breno C B; Raposo, Teresa P; Imamura, Louise M; Ingberman, Max; Hupp, Ted; Vojtěšek, Bořivoj; Argyle, David J Journal: Antibody therapeutics Issue: Volume 3:Number 3(2020) Page Start: 193 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. A comparison of anti-HER2 IgA and IgG1 in vivo efficacy is facilitated by high N-glycan sialylation of the IgA. Issue 1 (2nd January 2016) Authors: Rouwendal, Gerard JA; van der Lee, Miranda M; Meyer, Saskia; Reiding, Karli R; Schouten, Jan; de Roo, Guy; Egging, David F; Leusen, Jeanette HW; Boross, Peter; Wuhrer, Manfred; Verheijden, Gijs F; Dokter, Wim H; Timmers, Marco; Ubink, Ruud Journal: MAbs Issue: Volume 8:Issue 1(2016) Page Start: 74 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗